Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

Oct. 7, 2024 — Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell ... Why Children With Down Syndrome Have Higher Risk of Leukemia Sep. 25 ...

which is traditionally treated with a stem-cell transplant. Around 5,500 people are diagnosed with DLBCL in the UK each year, ...

Auron will present acute myeloid leukemia (AML) cell line-based activity, as well as ex vivo and in vivo patient derived xenograft data from AUTX-703, its oral, potent and selective degrader targeting ...

In a Enzalutamide resistant prostate cancer cell line, treatment with AUTX-703 alone ... including acute myeloid leukemia. For more information, please visit aurontx.com. Contact: Renee Leck ...

These findings provided support for the dual approach in the first-line setting ... marked by increased infiltration of suppressive myeloid cells and a reduction in CD8+ effector T cells.

myeloid and lymphoid cell lines. The myeloid cell line normally produces granulocytes, erythrocytes, thrombocytes, macrophages and mast cells; the lymphoid cell line produces B, T, NK and plasma ...